This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Multiple system atrophy (MSA)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Multiple system atrophy (MSA) is a fatal, adult-onset, neurodegenerative disease with rapid progression and limited symptomatic treatment options

  • clinical features include parkinsonism and cerebellar and autonomic signs and symptoms in various combinations
    • two major motor variants are distinguished according to the predominant motor presentation:
      • MSA parkinsonian variant (MSA-P) and
      • MSA cerebellar variant (MSA-C)
  • in Europe and North America, the distribution is in favor of the MSA-P variant, whereas MSA-C is more prevalent in Japan.
    • neuropathological correlates of MSA-P and MSA-C are striatonigral degeneration and olivopontocerebellar atrophy, respectively

Shy-Drager syndrome is considered another form of MSA.

Pathologically multiple system atrophy is characterised by widespread neuronal loss and gliosis.

Clinically there are three distinct pictures according to which parts of the brain are most severely affected:

  • cerebellar ataxia in OPCA (MSA-C)
  • Parkinsonism in strionigral degeneration (MSA-P)
  • autonomic failure in Shy-Drager syndrome

Reference:

  • Wenning GK, Ben Shlomo Y, Magalhaes M, Daniel SE, Quinn NP. Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain. 1994;117:835-845
  • Kollensperger M, Geser F, Ndayisaba JP, et al. Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry. Mov Disord. 2010;25:2604-2612
  • Tolosa, E. & Berciano, J. (1993). Choreas, hereditary and other ataxias, tics, myoclonus and other movement disorders. Curr Op Neurol Neurosurg. 6, 358-368.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.